The development of donor specific human leukocyte antigen (HLA) antibodies (DSA) as already been identified as a risk factor for graft dysfuntion and poor survival in teh context of lung transplantation (LuTx), but available evidence is not conclusive. The aim of the study was to evaluate the possibly existing correlation between pre-existing and/or post transplant developing DSA and recipients' outcome.
Anti-HLA Antibodies before and after Lung Transplantation: A Role on Medium-Long Term Outcomes? / E. Benazzi, L. Morlacchi, A. Cannavò, L. Rosso, A. Palleschi, V. Rossetti, I. Righi, S. Passamonti, B. Dalpedri, E. Longhi, M. Cardillo, P. Tarsia. ((Intervento presentato al convegno ISHLT Annual meeting and Scientific Sessions tenutosi a Orlando nel 2019.
Anti-HLA Antibodies before and after Lung Transplantation: A Role on Medium-Long Term Outcomes?
L. Rosso;A. Palleschi;
2019-04
Abstract
The development of donor specific human leukocyte antigen (HLA) antibodies (DSA) as already been identified as a risk factor for graft dysfuntion and poor survival in teh context of lung transplantation (LuTx), but available evidence is not conclusive. The aim of the study was to evaluate the possibly existing correlation between pre-existing and/or post transplant developing DSA and recipients' outcome.
| File | Dimensione | Formato | |
|---|---|---|---|
|
ISHLT 2019 (antihla antibodies...).pdf
accesso aperto
Tipologia:
Publisher's version/PDF
Dimensione
1.57 MB
Formato
Adobe PDF
|
1.57 MB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
